Skip to main content

IQVIA Holdings Value Stock - Dividend - Research Selection

Iqvia s

ISIN: US46266C1053 , WKN: A2JSPM

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Here's Why You Should Retain IQV Stock in Your Portfolio Now

2026-04-10
IQVIA's AI push with NVIDIA, strategic deals and buybacks drive growth, but weakening liquidity raises concerns over near-term financial flexibility.

Evercore ISI Group Maintains Outperform on IQVIA Holdings, Lowers Price Target to $185

2026-04-08
Evercore ISI Group analyst Elizabeth Anderson maintains IQVIA Holdings (NYSE:IQV) with a Outperform and lowers the price target from $225 to $185.

IQVIA Holdings Inc. (IQV): Billionaire David Tepper Makes Minor Adjustment

2026-04-07
IQVIA Holdings Inc. (NYSE:IQV) is one of Billionaire David Tepper’s 10 Small and Midcap Stock Picks with Huge Upside Potential. IQVIA Holdings Inc. (NYSE:IQV) is a relatively recent addition to the 13F portfolio of Appaloosa Management LP. The fund first disclosed a stake in the company in the second quarter of 2025. This position comprised […]

A Look At IQVIA Holdings (IQV) Valuation After Recent Share Price Pullback

2026-04-07
IQVIA Holdings (IQV) is back on many investors’ screens after a sharp pullback, with the stock down about 29% over the past 3 months and roughly 24% year to date. See our latest analysis for IQVIA Holdings. The recent 90 day share price return of about a 29% decline and year to date share price return of about a 24% decline contrasts with a 1 year total shareholder return of 11.57%. This suggests shorter term momentum has faded even as longer term holders remain in positive territory. If...

IQVIA Holdings Inc. stock underperforms Monday when compared to competitors

2026-04-06
IQVIA Holdings Inc. stock underperforms Monday when compared to competitors

IQVIA (IQV) Launches IQVIA.ai Unified Agentic AI Platform with Nvidia

2026-04-05
IQVIA Holdings Inc. (NYSE:IQV) is one of the best large cap value stocks to buy according to analysts. On March 16, IQVIA Holdings announced the launch of IQVIA.ai, which is a unified agentic AI platform developed in collaboration with Nvidia. The platform is purpose-built for the life sciences industry to enhance operational efficiency and decision-making […]

Reflecting On Drug Development Inputs & Services Stocks’ Q4 Earnings: IQVIA (NYSE:IQV)

2026-04-02
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug development inputs & services industry, including IQVIA (NYSE:IQV) and its peers.

IQVIA Holdings Inc. stock outperforms competitors on strong trading day

2026-04-01
IQVIA Holdings Inc. stock outperforms competitors on strong trading day

IQVIA Holdings Inc. stock rises Tuesday, still underperforms market

2026-03-31
IQVIA Holdings Inc. stock rises Tuesday, still underperforms market

IQVIA Holdings Inc. stock underperforms Friday when compared to competitors

2026-03-27
IQVIA Holdings Inc. stock underperforms Friday when compared to competitors